Skip to main content

Advertisement

SpringerLink
Log in

Systemic mastocytosis associated with acute myeloid leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Swerdlow SH, Campo E, Harris NL et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, Revised 4t. IARC, Lyon

    Google Scholar 

  2. Cornet E, Dumézy F, Roumier C, Lepelley P, Jouy N, Philippe N, Renneville A, Berthon C, Nelken B, Quesnel B, Preudhomme C (2012) Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis. Leuk Res 36:1330–1333. https://doi.org/10.1016/j.leukres.2012.07.001

    Article  CAS  PubMed  Google Scholar 

  3. Pullarkat V, Bedell V, Kim Y, Bhatia R, Nakamura R, Forman S, Sun J, Senitzer D, Slovak ML (2007) Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res 31:261–265. https://doi.org/10.1016/j.leukres.2006.03.006

    Article  CAS  PubMed  Google Scholar 

  4. Pardanani A (2018) Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management. Am J Hematol 94:363–377. https://doi.org/10.1002/ajh.25371

    Article  Google Scholar 

  5. Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, McMahon G, Longley BJ (2002) The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 99:1741–1744. https://doi.org/10.1182/blood.V99.5.1741

    Article  CAS  PubMed  Google Scholar 

  6. Lim KH, Pardanani A, Butterfield JH, Li CY, Tefferi A (2009) Cytoreductive therapy in 108 adults with systemic mastocytosis: outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine. Am J Hematol 84:790–794. https://doi.org/10.1002/ajh.21561

    Article  CAS  PubMed  Google Scholar 

  7. Gotlib J, Kluin-Nelemans HC, George TI, Akin C, Sotlar K, Hermine O, Awan FT, Hexner E, Mauro MJ, Sternberg DW, Villeneuve M, Huntsman Labed A, Stanek EJ, Hartmann K, Horny HP, Valent P, Reiter A (2016) Efficacy and safety of midostaurin in advanced systemic mastocytosis. N Engl J Med 374:2530–2541. https://doi.org/10.1056/NEJMoa1513098

    Article  CAS  PubMed  Google Scholar 

  8. Cairoli R, Beghini A, Grillo G, Nadali G, Elice F, Ripamonti CB, Colapietro P, Nichelatti M, Pezzetti L, Lunghi M, Cuneo A, Viola A, Ferrara F, Lazzarino M, Rodeghiero F, Pizzolo G, Larizza L, Morra E (2006) Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood 107:3463–3468. https://doi.org/10.1182/blood-2005-09-3640

    Article  CAS  PubMed  Google Scholar 

  9. Duployez N, Marceau-Renaut A, Boissel N, Petit A, Bucci M, Geffroy S, Lapillonne H, Renneville A, Ragu C, Figeac M, Celli-Lebras K, Lacombe C, Micol JB, Abdel-Wahab O, Cornillet P, Ifrah N, Dombret H, Leverger G, Jourdan E, Preudhomme C (2016) Comprehensive mutational profiling of core binding factor acute myeloid leukemia. Blood 127:2451–2459. https://doi.org/10.1182/blood-2015-12-688705

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital das Clínicas, Universidade Federal de Minas Gerais, Prof Alfredo Balena 190, Santa Efigênia, Belo Horizonte, Minas Gerais, 30130-100, Brazil

    Frederico Lisboa Nogueira, Naira Neves Neto Martins, Patrícia Santos Resende Cardoso, Mitiko Murao, Frederico Henrique Correa de Melo, Ana Beatriz Firmato Glória & Evandro Maranhão Fagundes

Authors
  1. Frederico Lisboa Nogueira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naira Neves Neto Martins
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patrícia Santos Resende Cardoso
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mitiko Murao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frederico Henrique Correa de Melo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ana Beatriz Firmato Glória
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Evandro Maranhão Fagundes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Evandro Maranhão Fagundes.

Ethics declarations

Informed consent was obtained from the patient described in this letter.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nogueira, F.L., Martins, N.N.N., Cardoso, P.S.R. et al. Systemic mastocytosis associated with acute myeloid leukemia. Ann Hematol 99, 195–196 (2020). https://doi.org/10.1007/s00277-019-03806-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03806-8

Search

Navigation